Diagnostics

Reference lab, Roche Diagnostics signs agreement to offer assay for genetic testing

Published in Gene Therapy Weekly, November 10th, 2005

Specialty Laboratories (SP) (Specialty), a hospital-focused clinical reference laboratory, announced that it has signed an agreement with Roche Diagnostics Corp. (Roche) to begin offering the AmpliChip CYP450 assay, a microarray-based test for in vitro diagnostic use.

Test results using the AmpliChip CYP450, which is powered by Affymetrix microarray technology, will allow physicians to consider genetic information from patients in selecting medications and doses for a several common conditions such as pain medication, cardiac disease, cancer and depression. The AmpliChip CYP450 assay analyzes a patient's Cytochrome P450 2D6 and 2C19 genotypes from genomic DNA extracted...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-11-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry